Paravertebral Versus Caudal Block in Pediatric PCNL

Kidney Stones Clinical Trial

Official title:

Ultrasound Guided Thoracic Paravertebral Block Versus Ultrasound Guided Caudal Epidural Block in Pediatric Patients Undergoing Percutaneous Nephrolithotomy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05012215
• Other study ID #: Paravertebral Caudal PCNL
• Status: Recruiting
• Phase: N/A
• Start date: August 19, 2021
• Est. completion date: March 20, 2022

Study information

• Verified date: August 2021
• Source: Assiut University
• Contact: Hany M. Osman, M.D.
• Phone: +201002414591
• Email: hanymeo[@]aun.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To compare the efficacy of Ultrasound guided thoracic paravertebral block versus ultrasound guided caudal epidural block in pediatric patients undergoing percutaneous nephrolithotomy

Description:

Percutaneous Nephrolithotomy (PCNL) is a commonly performed surgical procedure for complex upper renal tract calculi. Although the skin incision for PCNL appears small, the intensity of intraoperative and postoperative pain is significant owing to soft tissue injury.

Paravertebral block is the technique of injecting local anesthetics in a space immediately lateral to where the spinal nerves emerge from the intervertebral foramina. This technique is used increasingly for intra-operative and post-operative.

Caudal epidural block involves placing a needle through the sacral hiatus to deliver medications into the epidural space. This approach is used widely used for surgical anesthesia and analgesia in pediatric patients.

this work aims to compare the efficacy of Ultrasound guided thoracic paravertebral block versus ultrasound guided caudal epidural block in pediatric patients undergoing percutaneous nephrolithotomy

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: March 20, 2022
• Est. primary completion date: March 20, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Years to 12 Years

Eligibility

Inclusion Criteria:

• Patients undergoing percutaneous nephrolithotomy

Exclusion Criteria:

• Coagulation disorders

• Infection at the site of injection

• Allergy to the local anesthetics used

• Spinal cord abnormalities or neurological deficits

Related Conditions & MeSH terms

• Kidney Calculi
• Kidney Stones
• Percutaneous Nephrolithotomy

Intervention

Procedure:
• Paravertebral
Ultrasound-guided paravertebral block
• Caudal block
Caudal block

Locations

Country	Name	City	State
Egypt	Assiut University	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood pressure during surgery in mmHg		through the surgery, an average of 2 hours
Primary	Heart rate (beats/minute)		through the surgery, an average of 2 hours
Primary	The concentration of sevoflurane in %		through the surgery, an average of 2 hours
Primary	Postoperative pain using FLACC score		up to 12 hours